Shares of Gilead Sciences Inc. GILD, -0.54% sank 0.54% to $83.62 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX, +1.10% rising 1.10% to 4,060.43 and the Dow Jones Industrial Average DJIA, +0.61% rising 0.61% to 33,949.41. The stock’s fall snapped a three-day winning streak. Gilead Sciences Inc. closed $6.12 short of its 52-week high ($89.74), which the company achieved on December 13th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson JNJ, -0.37% fell 0.37% to $168.89, Pfizer Inc. PFE, -0.92% fell 0.92% to $44.25, and Abbott Laboratories ABT, +0.06% rose 0.06% to $111.07. Trading volume (3.7 M) remained 3.5 million below its 50-day average volume of 7.2 M.